Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure

Danielle Rasooly(Brigham and Women's Hospital), Juan P. Casas(Novartis (Switzerland)), Maik Pietzner(University of Freiburg), Liam Gaziano(VA Boston Healthcare System), Jennifer E. Huffman(Harvard University), Daniel Posner(VA Boston Healthcare System), Patricia B. Munroe(Queen Mary University of London), Nicole Kosik(VA Boston Healthcare System), John C. Whittaker(University of Cambridge), Brian Charest(VA Boston Healthcare System), Eric Farber‐Eger(Vanderbilt University), Claudia Giambartolomei(University College London), Alexandre C. Pereira(University of Washington), Andrew R. Leach(LifeArc), Gina M. Peloso(Boston University), Yan V. Sun(Utah State University), Krishna G. Aragam(Massachusetts General Hospital), Eleanor Wheeler(AstraZeneca (United Kingdom)), Brian R. Ferolito(VA Boston Healthcare System), Kelly Cho(VA Boston Healthcare System), Jacob Joseph(Lourdes Hospital), María Paula Magariños(European Bioinformatics Institute), Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Quinn S. Wells(Vanderbilt University), Nay Aung(Queen Mary University of London), Lawrence S. Phillips(Emory University), A. Patrícia Bento(European Bioinformatics Institute), Steffen E. Petersen(Queen Mary University of London), Qin Hui(China-Japan Friendship Hospital), Chang Liu(Emory University), Zeyuan Wang(Emory University), Peter W.F. Wilson(VA Tennessee Valley Healthcare System), John Michael Gaziano(Brigham and Women's Hospital), Hesam Dashti(Broad Institute)
medRxiv
April 18, 2022
Cited by 10


Related Papers